Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
124.73
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Illumina Inc
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Agrigenomics Market Worth $5.3 Billion by 2026
June 17, 2021
Northbrook, IL -- (SBWIRE) -- 06/17/2021 -- Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer),...
Via
SBWire
Illumina Celebrates Pride Month
June 17, 2021
SOURCE: Illumina
Via
3BL Media
Agrigenomics Market Will Hit Big Revenues In Future | Key Players are Eurofins Scientific, Agilent Technologies, Inc., LGC Limited, Illumina, Inc., and Zoetis Inc.
June 16, 2021
Via
AB Newswire
Illumina Announces the Thirteenth Agricultural Greater Good Grant Winner
June 15, 2021
SOURCE: Illumina
Via
3BL Media
Record-breaking Achievement at Rady Children's Institute for Genomic Medicine
June 14, 2021
SOURCE: Illumina
Via
3BL Media
Illumina Celebrates World Oceans Day
June 08, 2021
SOURCE: Illumina
Via
3BL Media
Illumina Celebrates AAPI Heritage Month
May 26, 2021
SOURCE: Illumina
Via
3BL Media
Unlocking the Covid Code
May 17, 2021
SOURCE: Illumina
Via
3BL Media
Topics
Earnings
Exposures
COVID-19
Financial
DNA Data Storage Alliance Publishes First White Paper, Launches Website
June 10, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Molecular Biology Enzymes and Kits & Reagents Market Worth $29.7 Billion by 2026 - Exclusive Report by MarketsandMarkets™
June 08, 2021
The global molecular biology enzymes market is projected to $29.7 billion by 2026. Molecular biology enzymes and kits & reagents market report provides crucial industry insights that will help your...
Via
SBWire
Illumina Recognized in Just Capital's Top 100 Companies Supporting Healthy Families & Communities
June 07, 2021
SOURCE: Illumina
Via
3BL Media
San Diego Squared Is Empowering Tomorrow's STEM Leaders Today
May 13, 2021
SOURCE: Illumina
Via
3BL Media
Bringing Bright Minds Together at SPARK
May 07, 2021
SOURCE: Illumina
Via
3BL Media
Kansas City Lights the Night with a New Research Institute
April 30, 2021
SOURCE: Illumina
Via
3BL Media
Asia Pacific Single-Cell Analysis Market – High Growth Potential of Single-Cell Sequencing
June 09, 2021
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1%
Via
SBWire
Illumina and Microba Life Sciences Partner to Accelerate Microbiome Research
June 04, 2021
SOURCE: Illumina
Via
3BL Media
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
June 01, 2021
From
Illumina, Inc.
Via
Business Wire
Illumina To Webcast Upcoming Investor Conference
May 27, 2021
From
Illumina, Inc.
Via
Business Wire
PCR- and NGS-Based Diagnostic Testing Market Revenue to Cross USD 26.5 Bn by 2027: Global Market Insights Inc.
May 26, 2021
Major PCR- and NGS-based diagnostic testing market players include Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Eppendorf AG; Fluotics; Hamilton Company; Illumina, Inc.; Integra LifeScience...
Via
Newswire.com
Topics
Death
Exposures
COVID-19
Death
Illumina Celebrates International Biodiversity Day
May 24, 2021
SOURCE: Illumina
Via
3BL Media
Topics
Climate Change
Exposures
Climate
Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
May 17, 2021
From
Illumina, Inc.
Via
Business Wire
Immuno Oncology Assays Market Worth $7.9 Billion by 2026 - Exclusive Report by MarketsandMarkets™
May 07, 2021
The global immuno-oncology assays market is projected to reach $7.9 billion by 2026. Cancer cell-based assays market report provides crucial industry insights that will help your business grow.
Via
SBWire
Tumor Genomics Market Share, Industry Growth, Trend, Statistics, Drivers, Demand, Key Companies by 2028
May 07, 2021
Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for cancer-specific diagnostics are factors driving global tumor genomic...
Via
SBWire
Exposures
COVID-19
Forensic Equipment and Supplies Market Trends, Analysis, Demand and Global Industry Research Report, Region, and Segment Forecasts, 2021-2028
May 06, 2021
The growing significance of DNA analysis in criminal investigations and the rising number of forensic laboratories are the key factors fueling the growth of this market
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
DNA Sequencing in Drug Discovery Market Worth Observing Growth: Sigma-Aldrich, Siemens Healthcare Diagnostics, Promega
May 17, 2021
The DNA Sequencing In Drug Discovery Market research study presents insights into the changing competitive landscape and offers clients an accurate picture of the future direction of this industry. (To...
Via
SBWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Next-Generation Sequencing (NGS) Market Worth $24.2 Billion by 2026 - Exclusive Report by MarketsandMarkets™
May 05, 2021
The next-generation sequencing market is projected to reach $24.2 billion by 2026. NGS market report provides crucial industry insights that will help your business grow.
Via
SBWire
HLA Typing for Transplant Market Size USD 1,206.02 Million by 2028 Says a New Research Report by Reports and Data
May 03, 2021
HLA matching boosts development of new healthy blood cells and reduces the chances of graft-versus-host disease.
Via
SBWire
Illumina To Webcast Upcoming Investor Conference
April 29, 2021
From
Illumina, Inc.
Via
Business Wire
Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
April 29, 2021
From
Illumina, Inc.
Via
Business Wire
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
April 28, 2021
From
Illumina, Inc.
Via
Business Wire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.